Praxis Precision Medicines, Inc. (PRAX)
367.90
-8.04
(-2.14%)
USD |
NASDAQ |
Aug 24, 16:00
367.90
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Debt to Equity Ratio : 0.0008 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0008 |
| March 31, 2026 | 0.001 |
| December 31, 2025 | 0.0001 |
| September 30, 2025 | 0.0013 |
| June 30, 2025 | 0.0019 |
| March 31, 2025 | 0.0024 |
| December 31, 2024 | 0.0031 |
| September 30, 2024 | 0.0043 |
| June 30, 2024 | 0.0046 |
| March 31, 2024 | 0.0097 |
| December 31, 2023 | 0.0358 |
| September 30, 2023 | 0.0318 |
| June 30, 2023 | 0.0285 |
| March 31, 2023 | 0.0506 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.046 |
| September 30, 2022 | 0.0355 |
| June 30, 2022 | 0.0285 |
| March 31, 2022 | 0.0224 |
| December 31, 2021 | 0.0172 |
| September 30, 2021 | 0.0149 |
| June 30, 2021 | 0.0135 |
| March 31, 2021 | 0.0022 |
| December 31, 2020 | 0.0027 |
| September 30, 2020 | 0.0087 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.0364 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Heron Therapeutics, Inc. | 21.48 |
| Insmed, Inc. | 0.9865 |
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Perspective Therapeutics, Inc. | 0.0122 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.390B |
| Total Liabilities (Quarterly) | 49.06M |
| Shareholders Equity (Quarterly) | 1.341B |
| Current Ratio | 15.73 |